128 new cases recorded in Delhi bringing the total number of cases to 2,376
The total number of cases in Delhi rose to 2,376 on Thursday with 128 new cases and two deaths being recorded in a single day.
Of the total number of 50 fatalities reported till date, 27 of them were aged 60 years and above, 13 were in the range of 50-59 while 10 were below 50 years of age.
With two more fatalities, the death toll from Covid-19 in Delhi has risen to 50.
| 01 Mar |
 India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?The potential rewards are enormous a robust, efficient, and competitive pharmaceutical industry that not only fuels domestic growth but also serves as a reliable supplier of essential medicines to the world. View |
| 27 Feb |
 India’s Newborns Are Dying from Sepsis And No One Is Talking About ItNewborn sepsis is a complex problem that requires innovative solutions. More funding for research on rapid diagnostic tests, alternative treatments is essential to tackle this growing crisis. View |
| 26 Feb |
 The Corporate Invasion of Indian Hospitals: What It Means for YouThe question remains: will India’s hospital sector continue on its current trajectory and become a global leader in healthcare, or will the challenges of cost, infrastructure, and regulatory hurdles slow down this remarkable journey. View |
| 24 Feb |
 The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing SystemThe NMC’s strategy to allow non-medical faculty and offer incentives for non-clinical PG courses may help in the short term, but a broader shift in how medical education is structured is necessary. View |
| 24 Feb |
 The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West AfricaStricter regulations, greater transparency, and proactive enforcement are the only ways to ensure that India’s “pharmacy of the world” reputation is built on trust and safety, not on scandals and cover-ups. View |
| 21 Feb |
 India vs. Trump’s Pharma Tariff: The Battle Over Affordable MedicineIndian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India needs the U.S. market. View |
| 21 Feb |
 Odisha’s Bold Healthcare Vision: A Rs 12,000 Crore Blueprint for Universal Health AccessThe ambitious policies outlined in this budget signal a new era of healthcare reforms, ensuring that no citizen is denied medical treatment due to financial or geographical constraints. View |
| 19 Feb |
 Tata’s ₹500-Crore Gamble: Is Healthcare the New Playground for India’s Corporate Giants?As India’s healthcare sector continues to evolve, corporate giants like Tata are not just participants but key drivers of change. View |
| 19 Feb |
 Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery WaveAIIMS sets a precedent for other hospitals across India to follow. If robotic surgery becomes more widespread, the dream of world-class healthcare for all Indians may not be as distant as it once seemed. View |
| 12 Feb |
 First in India: Dr. Anshumala Shukla-Kulkarni Becomes Asia’s First Certified Endometriosis SpecialistDelayed diagnosis remains one of the biggest challenges. More awareness campaigns, educational programs, and inclusion of endometriosis can help detect the condition early and improve treatment outcomes. View |
 |
 |
 |
 |
-Advertisements-
.jpeg)
Friday, March 14, 2025
.jpg)
.jpeg)